Frances Richards
Frances Richards
Senior Research Associate at The University of Cambridge
Verified email at
Cited by
Cited by
ldentification of the von Hippel-Lindau disease tumor suppressor gene
F Latif, K Tory, J Gnarra, M Yao, FM Duh, ML Orcutt, T Stackhouse, ...
Science 260 (5112), 1317-1320, 1993
Familial gastric cancer: overview and guidelines for management*
C Caldas, F Carneiro, HT Lynch, J Yokota, GL Wiesner, SM Powell, ...
Journal of Medical Genetics 36 (12), 873-880, 1999
Germline mutations in the Von Hippel‐Lindau disease (VHL) gene in families from North America, Europe, and Japan
B Zbar, T Kishida, F Chen, L Schmidt, ER Maher, FM Richards, ...
Human mutation 8 (4), 348-357, 1996
Somatic mutations of the von Hippel—Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma
K Foster, A Prowse, A van den Berg, S Fleming, MMF Hulsbeek, ...
Human molecular genetics 3 (12), 2169-2173, 1994
Identification of intragenic mutations in the Von Hippel—Lindau disease tumour suppressor gene andcorrelation with disease phenotype
PA Crossey, FM Richards, K Foster, A Prowse, F Latlf, MI Lerman, B Zbar, ...
Human molecular genetics 3 (8), 1303-1308, 1994
Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer
FM Richards, SA McKee, MH Rajpar, TRP Cole, DGR Evans, ...
Human molecular genetics 8 (4), 607-610, 1999
Combenefit: an interactive platform for the analysis and visualization of drug combinations
GY Di Veroli, C Fornari, D Wang, S Mollard, JL Bramhall, FM Richards, ...
Bioinformatics 32 (18), 2866-2868, 2016
Somatic inactivation of the VHL gene in Von Hippel-Lindau disease tumors.
AH Prowse, AR Webster, FM Richards, S Richard, S Olschwang, ...
American journal of human genetics 60 (4), 765, 1997
Epigenetic inactivation of the RASSF1A 3p21. 3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma
C Morrissey, A Martinez, M Zatyka, A Agathanggelou, S Honorio, D Astuti, ...
Cancer research 61 (19), 7277-7281, 2001
Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations.
ER Maher, AR Webster, FM Richards, JS Green, PA Crossey, SJ Payne, ...
Journal of medical genetics 33 (4), 328-332, 1996
Identification of CDH1 germline missense mutations associated with functional inactivation of the E-cadherin protein in young gastric cancer probands
G Suriano, C Oliveira, P Ferreira, JC Machado, MC Bordin, O De Wever, ...
Human molecular genetics 12 (5), 575-582, 2003
Zebrafish based assays for the assessment of cardiac, visual and gut function—potential safety screens for early drug discovery
S Berghmans, P Butler, P Goldsmith, G Waldron, I Gardner, Z Golder, ...
Journal of pharmacological and toxicological methods 58 (1), 59-68, 2008
Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a …
M Zatyka, NF da Silva, SC Clifford, MR Morris, MS Wiesener, KU Eckardt, ...
Cancer research 62 (13), 3803-3811, 2002
Molecular genetic investigations of the mechanism of tumourigenesis in von Hippel-Lindau disease: analysis of allele loss in VHL tumours
PA Crossey, K Foster, FM Richards, ME Phipps, F Latif, K Tory, MH Jones, ...
Human genetics 93 (1), 53-58, 1994
SPARC independent drug delivery and antitumour effects of nab-paclitaxel in genetically engineered mice
A Neesse, KK Frese, DS Chan, TE Bapiro, WJ Howat, FM Richards, ...
Gut 63 (6), 974-983, 2014
Fibroblast drug scavenging increases intratumoural gemcitabine accumulation in murine pancreas cancer
E Hessmann, MS Patzak, L Klein, N Chen, V Kari, I Ramu, TE Bapiro, ...
Gut 67 (3), 497-507, 2018
Cyclosporine, FK506, and rapamycin: some effects on early activation events in serum-free, mitogen-stimulated mouse spleen cells
Transplantation 49 (4), 798-802, 1990
Molecular analysis of de novo germline mutations in the von Hippel-Lindau disease gene
FM Richards, SJ Payne, B Zbar, NA Affara, MA Ferguson-Smith, ...
Human molecular genetics 4 (11), 2139-2143, 1995
Design, Synthesis, and Biological Evaluation of an Allosteric Inhibitor of HSET that Targets Cancer Cells with Supernumerary Centrosomes
CA Watts, FM Richards, A Bender, PJ Bond, O Korb, O Kern, M Riddick, ...
Chemistry & biology 20 (11), 1399-1410, 2013
Accumulation and metabolism of drugs and CYP probe substrates in zebrafish larvae
W Alderton, S Berghmans, P Butler, H Chassaing, A Fleming, Z Golder, ...
Xenobiotica 40 (8), 547-557, 2010
The system can't perform the operation now. Try again later.
Articles 1–20